Philip Keegan
Results-driven program manager leading biopharma innovation
Philip Keegan is an accomplished molecular biologist with extensive expertise in assay development and target identification and validation. With a Ph.D. in Biomedical Engineering from the Georgia Institute of Technology and a Bachelor's Degree in the same field from Boston University, Keegan has made significant contributions to multiple organizations in various capacities.
Keegan's areas of expertise include sickle cell disease, inflammation, cardiovascular disease, tissue remodeling, and enzyme/protease biology. He has excellent analytical, technical, interpersonal, and communication skills and has proved time and again to be a motivated, result-driven team player.
Keegan has worked as a Public-Private Partnership Lead at Forward BIO Institute, Senior Member of Technical Staff at Draper, Research Scientist at New Health Sciences, Inc., and Whitaker Research Fellow at the University of the Witwatersrand. He has also served as a Doctoral Research Fellow and Laboratory Manager at the Georgia Institute of Technology, a Harvard Medical School Undergraduate Research Assistant, an MIT Undergraduate Research Assistant, and a Boston University Undergraduate Research Assistant.
Keegan's proficiency in transgenic animal breeding & husbandry, primary blood cell isolation, mammalian cell culture, ELISA & BioPlex, MACS, transfection, immunohistochemistry, qRT-PCR, immunoprecipitation, SDS-PAGE, Western blot & zymography makes him stand out in his field.
